Tirosin Kinase Inhibitors

DRUG2 trials

Sponsors

Spanish Lung Cancer Group, Azienda USL Reggio Emilia - IRCCS

Conditions

CVD - Cardiovascular DiseaseChronic Myelocytic LeukemiaErectile DysfunctionsNSCLC Stage IVTyrosine Kinase Inhibitor

Unknown Phase

T790M Mutation Testing in Blood by Different Methodologies

CompletedNCT03363139

Spanish Lung Cancer GroupNSCLC Stage IV

Start: 2018-03-01End: 2019-03-30Updated: 2020-04-08

A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia

RecruitingNCT07061145

Azienda USL Reggio Emilia - IRCCSChronic Myelocytic Leukemia, CVD - Cardiovascular Disease, Erectile Dysfunctions +1

Start: 2025-07-01End: 2028-12-01Target: 350Updated: 2026-08-07

Related Papers

Comprehensive cross-platform comparison of methodologies for noninvasive EGFR mutation testing: Results of the RING observational trial.

Journal of Clinical Oncology2020-05-201 citations